NCT07059312View on ClinicalTrials.gov

A Phase 1 Study of JADE101 in Healthy Participants

PHASE1RecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 17, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Healthy Volunteers
Interventions
DRUG

JADE101

JADE101 is supplied as sterile solution to be administered by SC injection.

DRUG

Placebo

Placebo solution to be administered at a matching volume by SC injection.

Trial Locations (1)

Unknown

RECRUITING

NZCR, Auckland

Sponsors
All Listed Sponsors
lead

Jade Biosciences, Inc.

INDUSTRY

NCT07059312 - A Phase 1 Study of JADE101 in Healthy Participants | Biotech Hunter | Biotech Hunter